C9orf64 has been reported as an epigenetic biomarker that distinguishes patients with NSCLC from those with nonmalignant lung disease at the transcriptional level (29) and has a higher level of methylation in ovarian cancer (30). Here, QNG1 is linked to non-small cell lung carcinoma.